LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-09-21
Case ID: NM_000314.8_c.521del_20260921_142420
Framework: ACMG/AMP 2015
Variant classification summary

NM_000314.8:c.521del

PTEN  · NP_000305.3:p.(Tyr174LeufsTer9)  · NM_000314.8
GRCh37: chr10:89711902 TA>T  ·  GRCh38: chr10:87952145 TA>T
Gene: PTEN Transcript: NM_000314.8
Final call
Likely Pathogenic
PVS1 very strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
PTEN
Transcript
NM_000314.8
Protein
NP_000305.3:p.(Tyr174LeufsTer9)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PVS1 very strong: the frameshift is 5′ of PTEN p.D375/c.1121 and meets the Expert Panel's nonsense-mediated-decay rule.
2
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1, below the PTEN population-frequency threshold.
Final determination: PTEN Expert Panel Rule20 classifies a variant as Likely Pathogenic when one Pathogenic.Very Strong criterion and one Pathogenic.Supporting criterion are met; here these are PVS1 very strong and PM2 supporting.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Met at very strong strength: NM_000314.8:c.521del causes p.(Tyr174LeufsTer9), a frameshift 5′ of p.D375/c.1121, meeting the PTEN VCEP NMD branch.
cspec vcep_pvs1_decisiontree_pten
PS1 N/A Not applicable: c.521del is a frameshift producing p.(Tyr174LeufsTer9), not a missense or splice-site variant eligible for the PTEN VCEP PS1 rule.
cspec
PS2 Not assessed Not assessed: no proband diagnosis, parental testing, maternity/paternity confirmation, or family-history data are documented.
cspec
PS3 Not assessed Not assessed: the PTEN VCEP assay table is restricted to missense variants, and no c.521del or p.Tyr174LeufsTer9 entry was found.
cspec vcep_mmc2 PMID:11237521 PMID:17218262
PS4 Not assessed Not assessed: no case-control enrichment, confidence interval, or variant-specific phenotype score is available for applying the PTEN PS4 thresholds.
cspec
PM1 Not assessed Not assessed: PTEN Y174 is reported as a hotspot, but the partial hotspot source lacks a valid source_registry key required to audit PM1 evidence.
cspec
PM2 Met Met, supporting: the variant is absent (observed allele frequency 0) in gnomAD v2.1 and v4.1, below the PTEN PM2 threshold of 0.00001.
cspec gnomad_v2 gnomad_v4
PM3 N/A Not applicable: the PTEN VCEP explicitly excludes PM3 for this autosomal dominant disorder.
cspec
PM4 N/A Not applicable: the PTEN VCEP PM4 rule covers in-frame indels or stop-loss variants, whereas c.521del is a frameshift.
cspec
PM5 N/A Not applicable: c.521del is a frameshift producing p.(Tyr174LeufsTer9), whereas PM5 requires a missense change and a same-residue missense comparator.
cspec
PM6 Not assessed Not assessed: no qualifying assumed de novo observation, proband disease documentation, family history, or count of independent observations is available.
cspec
PP1 Not assessed Not assessed: no affected relatives, co-segregation observations, family structure, or meiosis count are documented.
cspec
PP2 N/A Not applicable: PP2 requires a missense variant, while c.521del is a PTEN frameshift producing p.(Tyr174LeufsTer9).
cspec
PP3 N/A Not applicable: NM_000314.8:c.521del is a frameshift variant, outside PP3's missense or intronic/splice-region computational-evidence scope.
cspec pvs1_variant_assessment
PP4 N/A Not applicable: the PTEN Expert Panel incorporates phenotype specificity into PS4 and explicitly excludes PP4.
cspec
PP5 N/A Not applicable: ClinVar has no exact-variant expert-panel pathogenic classification, and the PTEN framework excludes PP5.
cspec clinvar
BA1 Not met Not met: the variant is absent from gnomAD v2.1 and v4.1, rather than exceeding the PTEN BA1 threshold of 0.00056 (0.056%).
cspec gnomad_v2 gnomad_v4
BS1 Not met Not met: the variant is absent from gnomAD, so its frequency does not fall within the PTEN BS1 interval of 0.0000043–0.00056.
cspec gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: no confirmed homozygous observation in a healthy or PHTS-unaffected individual is available for this absent variant.
cspec gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no applicable benign functional assay was found, and the governing PTEN table contains no entry for this frameshift variant.
cspec vcep_mmc2 PMID:11237521 PMID:17218262
BS4 Not assessed Not assessed: no non-segregating affected relatives, family segregation results, or number of families are documented.
cspec
BP1 N/A Not applicable: the PTEN VCEP marks BP1 as not applicable, and c.521del is a frameshift producing p.(Tyr174LeufsTer9).
cspec
BP2 Not assessed Not assessed: no second pathogenic PTEN variant or cis/trans phase observation is documented for the required BP2 evidence.
cspec
BP3 N/A Not applicable: the PTEN VCEP lists BP3 as not applicable, and c.521del is a frameshift rather than an in-frame repeat-region deletion.
cspec
BP4 N/A Not applicable: NM_000314.8:c.521del is a frameshift variant, outside BP4's missense or intronic/splice-region computational-evidence scope.
cspec pvs1_variant_assessment
BP5 Not assessed Not assessed: no two qualifying cases with a highly penetrant alternate diagnosis and non-overlapping PTEN history are documented.
cspec
BP6 N/A Not applicable: the PTEN Expert Panel excludes BP6 and ClinVar has no exact-variant expert-panel benign classification.
cspec clinvar
BP7 N/A Not applicable: NM_000314.8:c.521del is a frameshift variant, not a synonymous variant eligible for BP7.
cspec pvs1_variant_assessment
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.